Cryoport Unveils Innovative MVE Biological Vapor Shippers for Life Sciences

Cryoport Launches New MVE Biological Solutions Vapor Shippers

Cryoport, Inc., a recognized leader in temperature-controlled logistics for the life sciences sector, has announced the rollout of its latest vapor shipper models, the SC 4/2V and SC 4/3V. With their cutting-edge design and enhanced features, these transport solutions provide medical professionals, researchers, and pharmaceutical companies with a more reliable means of handling sensitive biological materials.

Enhanced Safety and Reliability

Straight from MVE Biological Solutions' legacy design, the latest vapor shipper models prioritize safety during transit, ensuring that critical biological materials such as cells, tissues for therapies, and veterinary vaccines remain intact even through challenging conditions. The SC 4/2V and SC 4/3V shippers are specifically engineered to maintain cryogenic temperatures over extended shipment times, an essential feature for entities involved in cell regeneration and biopharmaceutical operations.

One of the standout improvements lies in the substantial increase in hold times. The SC 4/2V now boasts a remarkable 19 days of temperature retention capability, up from 13 days in its predecessor. Meanwhile, the SC 4/3V extends this period to 26 days, offering practitioners greater peace of mind during possible transit delays.

Innovative Technology

These models also integrate MVE's proprietary BEND DON'T BREAK™ technology. This unique design element incorporates a flexible lid that mitigates impact damage, a common concern with rough handling often encountered in shipping scenarios. The emphasis on durability not only assists in preservation of the biological integrity but also reduces the total costs associated with reshipments resulting from damages.

Mike Duich, President and CEO of MVE Biological Solutions, underscores the company's commitment to advancements, pointing out that these innovations aim to meet the evolving needs of the market. Alongside longer hold times and reduced refill frequencies, the latest shippers are engineered to lower the operational costs associated with cryogenic transport. Duich comments, “These enhancements reflect our broader mission to support scientific progress with robust, dependable, and cost-efficient cryogenic systems.”

Jerrell Shelton, CEO of Cryoport, adds to the conversation about the pivotal role these advances will play in the sector. He highlights how vital temperature-sensitive materials are to life sciences and how mitigating risks within the supply chain enhances operational efficiency across the field.

“By providing longer temperature hold times, better protection against sudden shocks, and additional security features, we have significantly reduced the risks associated with handling temperature-sensitive materials,” Shelton states.

Additional Features for Enhanced Functionality

The SC 4/2V and SC 4/3V models include new security features like an integrated lid locking tab that minimizes the chances of breakage. The innovation doesn't stop there; the Vapor Shield Technology designed by MVE further protects these units, addressing potential vacuum loss that could arise from nitrogen overfill, addressing both functionality and safety.

The public now has the opportunity to learn more about these vapor shippers through Cryoport's online platforms. The company continues to emphasize that its solutions are pivotal in furthering progress within the life sciences domain.

Conclusion

Cryoport's continuous innovation and commitment to excellence signify a notable step forward in the realm of temperature-sensitive transport solutions. The SC 4/2V and SC 4/3V next-generation vapor shippers exemplify this ethos, providing enhanced reliability and safety for the critical materials that help advance scientific research and medical breakthroughs.

To learn more about Cryoport and its vapor shippers, visit Cryoport Inc..